Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines. 1990

R L Blakley, and F C Harwood, and K D Huff
Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.

The 2',3'-dideoxy analogues of cytidine, guanosine, adenosine, inosine, and thymidine have been compared for their cytostatic effects on 14 cell lines that include B lymphoblastic, T lymphoblastic, and myeloblastic lines. In all cases 2',3'-dideoxycytidine (ddCyd) was the most toxic nucleoside, with dideoxyguanosine (ddGuo) next, and little cytostatic action by the analogues of thymidine, adenosine, or inosine. The cytostatic action of ddCyd was examined in more detail. The concentration for 50% inhibition of growth over 4 days (IC50) was 0.2 to 3 microM for five T lymphoblastic lines. Although most B lymphoblastic and myeloblastic lines were less sensitive (IC50, 16-70 microM), some were as sensitive as the T lymphoblastic lines. The four lines most sensitive to ddGuo (three T lymphoblastic and one B lymphoblastic) had IC50 values of 47-80 microM. Two lines with high sensitivity to ddCyd had levels of ddCyd triphosphate about 4-7 times higher than those found in the two least sensitive after 1-, 3-, or 24-hr exposure to 3 microM [3H]ddCyd. This was associated with a much higher ratio of the diphosphate to the triphosphate in the least sensitive cells, an observation suggesting slow nucleoside diphosphate kinase action on the diphosphate of ddCyd in the resistant cells. Catabolism of the mono-, di-, and triphosphate was very slow in all cell lines, and in lines of low sensitivity disappearance of the triphosphate had a half life (approximately 19 hr) about twice as long as in sensitive lines. This may be due to continuing slow conversion of diphosphate to triphosphate after removal of nucleoside from the medium.

UI MeSH Term Description Entries
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D003854 Deoxyribonucleotides A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group. Deoxyribonucleotide
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D016047 Zalcitabine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. 2',3'-Dideoxycytidine,Dideoxycytidine,ddC (Antiviral),HIVID Roche,Hivid,NSC-606170,2',3' Dideoxycytidine,NSC 606170,NSC606170

Related Publications

R L Blakley, and F C Harwood, and K D Huff
December 1982, Immunopharmacology,
R L Blakley, and F C Harwood, and K D Huff
February 1976, Journal of the National Cancer Institute,
R L Blakley, and F C Harwood, and K D Huff
October 1976, The Journal of general virology,
R L Blakley, and F C Harwood, and K D Huff
October 2019, In vitro cellular & developmental biology. Animal,
R L Blakley, and F C Harwood, and K D Huff
January 1993, Cancer research,
R L Blakley, and F C Harwood, and K D Huff
June 1983, Journal of medicinal chemistry,
R L Blakley, and F C Harwood, and K D Huff
January 2015, Mutation research. Genetic toxicology and environmental mutagenesis,
R L Blakley, and F C Harwood, and K D Huff
January 1999, Nucleic acids symposium series,
Copied contents to your clipboard!